Table 4.
Frequencies of Malignancy Extension by the Treatment Arm
| Malignancy Population |
Type of Malignancy | Severity | Simvastatin Monotherapy | Simvastatin/Ezetimibe | p Value |
|---|---|---|---|---|---|
| Excluding skin malignancy | Solid tumor | Local (no spread beyond the primary organ) | 328 (49.6) | 304 (45.1) | 0.15 |
| Metastatic | 212 (32.1) | 230 (34.1) | |||
| Known to spread to contiguous structures | 84 (12.7) | 109 (16.2) | |||
| Unknown | 37 (5.6) | 31 (4.6) | |||
| Leukemia, lymphoma and other blood malignancy | Acute | 12 (18.5) | 13 (18.6) | 0.98 | |
| Chronic | 11 (16.9) | 11 (15.7) | |||
| Unknown | 42 (64.6) | 46 (65.7) | |||
| Including skin malignancy | Solid tumor | Local (no spread beyond the primary organ) | 507 (60.1) | 464 (55.6) | 0.12 |
| Metastatic | 212 (25.1) | 230 (27.5) | |||
| Known to spread to contiguous structures | 87 (10.3) | 110 (13.2) | |||
| Unknown | 37 (4.4) | 31 (3.7) |
Values are n (%).